• Ingrid Glurich Ph.D.

  • Emeritus Researcher

    • MCRI - MCRI-Cancer Care and Research
    • 1000 North Oak Ave. 1R4 Marshfield, WI 54449
    • (715) 389-3072


PhD, Microbiology, State University of New York at Buffalo, Buffalo
MS, Microbiology, State University of New York at Buffalo, Buffalo
BS, Medical Technology, State University of New York at Buffalo, Buffalo

Work Experience

2015 to Present:
Project Scientist, Institute for Oral and Systemic Health, Biomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield
2007 to Present:
University Associate, University of Stevens Point, Stevens Point
2000 to 2015:
Director, Office of Scientific Writing and Publication, Department of Medical Research, Marshfield Clinic Research Foundation, Marshfield
1995 to 1999:
Assistant Professor, Department of Oral Biology, School of Dentistry SUNY at Buffalo, Buffalo


Dr. Glurich is a microbiologist with expertise and training in oral immunity, autoimmune diseases, microbial pathogenesis. Her research interests span relationships between oral and systemic health, advancement of integrated care delivery, promotion of oral precision medicine and definition of clinical practice guidelines for oral health management in patients with rare disease impacted by oral, craniofacial abnormalities. She works as a project scientist advancing research intiatives within the Center for Oral and Systemic Health and serves as the Core leader for the Oral Precision Research Core.

Research Interests

Dr. Glurich's areas of interest include: oral microbiology including the role of oral microbiome in oral and systemic health, microbial pathogenesis, host immune responses, role of inflammation in disease establishment/progression, potential of identifying biomarkers for monitoring of oral disease status to promote clinical precision medicine, and further delineation of mechanisms underlying connections between oral and systemic disease processes. She also is interested in advancing integrated medical-dental care delivery and advancing understanding of oral and craniofacial abnormalities arising in the context of rare diseases that impact on oral and systemic health and establishment of clinical practice guidelines to assist dental and medical providers in interventional planning and management of affected individuals.

Select Publications

  • Albini B, Fagundis A, Glurich IE, Kerjaschki D, Neuland C, Noble C,...Penner E. (1981). Experimental models of immune complex disease. In: Steffan, Ludwig (Ed.), Clinical Immunology and Allergology (pp. 177-86). Amsterdam:: Elsevier/North Holland Biomedical Press;.
  • Albini B, Glurich IE, Andres GA. (1982). Mercuric Chloride-induced immunologically mediated diseases in experimental animals. In: Porter C (Ed.), Nephrotoxic Mechanisms: Monographs of the Fogarthy Foundation. (pp. 413-23). New York, NY:: Plenum Press;.
  • Penner E, Albini B, Glurich IE, Andres GA, Milgrom F. (1982). Dissociation of immune complexes in tissue sections by excess of antigen. Int Arch Allergy Appl Immunol.. 67(3):245-53.
  • Albini B, Nisengard RJ, Glurich IE, Neiders ME, Stinson M. (1985 March). Streptococcus mutans-induced nephritis in rabbits. Am J Pathol. 118(3):408-18.
  • Albini B, Glurich IE, Camusi G, Nisengard RJ, Stinson MW. (1987). Streptococcus mutans--induced tissue lesions in the rabbit: The nephritis. In: Kano K, Mori S, Sugisaki I, Torisu M. (Ed.), Cellular, Molecular, and Genetic Approaches to Immunodiagnosis and Immunotherapy. (pp. 269-75). Tokyo, Japan:: Univ. Tokyo Press;.
  • Kulesz-Martin M, Kozlowski P, Glurich IE, Lisafeld B, Hemedinger E, Kumar VR. (1989 July). Pemphigoid, pemphigus and desmoplakin as antigenic markers of differentiation in normal and tumorigenic mouse keratinocyte lines. Cell Tissue Kinet.. 22(4):279-90.
  • Kulesz-Martin M, Glurich IE, Lisafeld B, Kozlowski P. (1990 February). Induction by transforming growth factor beta of pemphigus vulgaris antigen activity in mouse papilloma cells. Cancer Res. 50(3):686-90.
  • Glurich IE, Winters B, Albini B, Stinson M. (1991 March). Identification of Streptococcus pyogenes proteins that bind to rabbit kidney in vitro and in vivo. Microb Pathog. 10(3):209-20.
  • Miyata M, Glurich IE, Kasukawa R, Milgrom F, Stinson M, Albini B. (1995 December). Streptococcus-mutans-induced nephritis in rabbits: rheumatoid factors and nephritogenicity. Int Arch Allergy Immunol.. 108(4):360-7.
  • Sharma AD, Sojar HT, Glurich IE, Honma K, Kuramitsu HK, Genco RJ. (1998 December). Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun. 66(12):5703-10.
  • Genco RJ, Glurich IE, Haraszthy V, Zambon J, De Nardin E. (2001 February). Overview of risk factors for periodontal disease and implications for diabetes and cardiovascular disease. Compend Contin Educ Dent. 22(2 Spec No):21-3.
    PubMed ID: 19248254
  • Glurich IE, Grossi S, Albini B, Ho A, Shah R, Zeid R,...De Nardin E. (2002 March). Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol. 9(2):425-32.
    PubMed ID: 11874889
  • Hillman MA, Wilke RA, Caldwell MD, Berg RL, Glurich IE, Burmester JK. (2004 August). Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype. Pharmacogenetics. 14(8):539-547.
    PubMed ID: 15284536
  • Yale SH, Medlin SC, Liang H, Peters TL, Glurich IE, Mazza JJ. (2005 September). Risk assessment model for venothromboembolism in post-hospitalized patients. Int Angiol. 24(3):250-254.
    PubMed ID: 16158034
  • Mazza JJ, Yale SH, Arrowood J, Reynolds CE, Glurich IE, Chyou P,...Reed KD [including Linneman JG.] (2005 November). Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res. 3(4):214-220.
    PubMed ID: 16303886
  • Bryce DA, Nelson J, Glurich IE, Berg RL. (2005 September). Intradiscal electrothermal annuloplasty therapy: a case series study leading to new considerations. WMJ. 104(6):39-46.
    PubMed ID: 16218315
  • Habash-Bseiso D, Yale SH, Glurich IE, Goldberg JW. (2005 July). Serologic testing in connective tissue diseases. Clin Med Res. 3(3):190-193.
    PubMed ID: 16160075
  • Giampietro PF, Raggio CL, Reynolds CE, Shukla SK, McPherson EW, Ghebranious N,...Blank RD [including Jacobsen FS, Kumar VR, Faciszewski T, Rasmussen K, Burmester JK, Zaleski CA, Merchant S, David DE, Weber JL, Glurich IE.] (2005 November). An analysis of PAX1 in the development of vertebral malformations. Clin Genet. 68(5):448-453.
    PubMed ID: 16207213
  • Yale SH, Glurich IE. (2005 June). Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med. 11(3):433-439.
    PubMed ID: 15992226
  • Hillman MA, Wilke RA, Yale SH, Vidaillet HJ, Caldwell MD, Glurich IE,...Burmester JK [including Berg RL, Schmelzer JR.] (2005 August). A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clin Med Res. 3(3):137-145.
    PubMed ID: 16160068
  • Maganti RK, Hausman NJ, Koehn MA, Sandok EK, Glurich IE, Mukesh BNanjan. (2006 February). Excessive daytime sleepiness and sleep complaints among children with epilepsy. Epilepsy Behav. 8(1):272-277.
    PubMed ID: 16352471
  • Giampietro PF, Raggio CL, Reynolds CE, Ghebranious N, Burmester JK, Glurich IE,...Blank RD [including Rasmussen K, McPherson EW, Shukla SK, Merchant S, Jacobsen FS, Faciszewski T.] (2006 October). DLL3 as a candidate gene for vertebral malformations. Am J Med Genet A. 140A(22):2447-2453.
    PubMed ID: 17041936
  • Ghebranious N, Burmester JK, Glurich IE, McPherson EW, Ivacic LC, Kislow JL,...Giampietro PF [including Rasmussen K, Kumar VR, Jacobsen FS, Faciszewski T.] (2006 June). Evaluation of SLC35A3 as a candidate gene for human vertebral malformations. Am J Med Genet A. 140(12):1346-1348.
    PubMed ID: 16691598
  • Yale SH, Mazza JJ, Glurich IE, Peters TL, Mukesh BNanjan. (2006 March). Recurrent venous thromboembolism in patients with and without anticoagulation after inferior vena caval filter placement. Int Angiol. 25(1):60-66.
    PubMed ID: 16520726
  • Caldwell MD, Berg RL, Zhang KQi, Glurich IE, Schmelzer JR, Yale SH,...Burmester JK [including Vidaillet HJ.] (2007 March). Evaluation of genetic factors for warfarin dose prediction. Clin Med Res. 5(1):8-16.
    PubMed ID: 17456829
  • Ghebranious N, Raggio CL, Blank RD, McPherson EW, Burmester JK, Ivacic LC,...Giampietro PF [including Rasmussen K, Kislow JL, Glurich IE, Jacobsen FS, Faciszewski T.] (2007 September). Lack of evidence of WNT3A as a candidate gene for congenital vertebral malformations. Scoliosis. 2 :13.
    PubMed ID: 17888180
  • Giampietro PF, Dunwoodie S, Kusumi K, Pourquie O, Tassy O, Offiah A,...Turnpenny PD. (2008 December). Molecular diagnosis of vertebral segmentation disorders in humans. Expert Opin Med Diagn. 2(10):1107-21.
  • Wesbrook SD, Giampietro PF, Glurich IE, McCarty CA, Peissig PL, Starren JB,...Vidaillet HJ [including Uphoff TS, Zaleski CA.] (2008 November). Marshfield Clinic, Marshfield Wisconsin/ Community Based Approaches to Personalized Health Care: Marshfield Clinic Personalized Health Care: Pioneers, Partnerships, Progress. :231-42.
  • Yale SH, Musana KA, Kieke AL, Hayes J, Glurich IE, Chyou P. (2008 May). Applying case definition criteria to irritable bowel syndrome. Clinical Medicine & Research. 6(1):9-16.
    PubMed ID: 18591372
  • Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P,...Burmester JK [including Schmelzer JR, Glurich IE, Vidaillet HJ, Yale SH, Zhang KQi, Berg RL.] (2008 April). CYP4F2 genetic variant alters required warfarin dose. BLOOD. 111(8):4106-12.
    PubMed ID: 18250228
  • Ghebranious N, Blank RD, Raggio CL, Staubli JC, McPherson EW, Ivacic LC,...Giampietro PF [including Rasmussen K, Jacobsen FS, Faciszewski T, Burmester JK, Glurich IE.] (2008 October). A missense T(Brachyury) Mutation Contributes to Vertebral Malformations. JOURNAL OF BONE AND MINERAL RESEARCH. 23(10):1576-83.
    PubMed ID: 18466071
  • Bailey H, Agger WA, Baumgardner D, Burmester JK, Cisler R, Everten J,...DeMets D [including Glurich IE, Yale SH.] (2009). The Wisconsin Network for Health Research (WiNHR): A Statewide, Collaborative, Multi-disciplinary, Research Group. Wis Med J. 108(9):453-458.
    PubMed ID: 20131687
  • Giampietro PF, Dunwoodie S, Kusumi K, Pourquie O, Tassy O, Offiah A,...Turnpenny PD [including Glurich IE.] (2009 January). Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans. Ann N Y Acad Sci. 1151 :38-67.
    PubMed ID: 19154516
  • Onitilo AA, McCarty CA, Wilke RA, Glurich IE, Engel JM, Flockhart DA,...Gin Y. (2009 June). Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. BREAST CANCER RESEARCH AND TREATMENT. 115(3):643-50.
    PubMed ID: 19082882
  • Glurich IE, Fleisner MA. (2010 December). Research Mentor: a web-based resource supporting grantsmanship and scientific publication. Clinical Medicine & Research. 8(3-4):173-75.
    PubMed ID: 20852087
  • Kumar DR, Hanlin E, Glurich IE, Mazza JJ, Yale SH. (2010 December). Virchow’s Contribution to the Understanding of Thrombosis and Cellular Biology. Clinical Medicine & Research. 8(3-4):168-72.
    PubMed ID: 20739582
  • Wiley CL, Switzer SP, Berg RL, Glurich IE, Dart RA. (2010 March). Association of B-type natriuretic peptide (BNP) levels with estimated glomerular filtration rate (eGFR) and congestive heart failure (CHF). Clinical Medicine & Research. 8(1):7-11.
    PubMed ID: 19920165
  • Glurich IE, Fleisner MA. (2010 March). Research Mentor: a web-based reference for planning and preparing a research proposal. Clinical Medicine & Research. 8(1):56.
  • Glurich IE, Burmester JK, Caldwell MD. (2010 May). Understanding the pharmacogenetic approach to warfarin dosing. HEART FAILURE REVIEWS. 13(3):239-48.
    PubMed ID: 18998206
  • Yazigi N, Yale S, Glurich, I, Schmelzer, J, Burmester, J, Berg, R, Caldwell, M. (2010). Modeling Clearance of Warfarin - Preliminary Report. J Gen Intern Med. 25(Suppl 3):334.
  • Ghebranious N, Mukesh BNanjan, Giampietro PF, Glurich IE, Mickel SF, Waring SC, McCarty CA. (2011 March). A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clin Med Res. 9(1):17-25.
    PubMed ID: 20682755
  • Burmester JK, Berg RL, Yale SH, Rottscheit CM, Glurich IE, Schmelzer JR, Caldwell MD. (2011 June). A randomized controlled trial of genotype-based Coumadin initiation. Genet Med. 13(6):509-18.
    PubMed ID: 21423021
  • Burmester JK, Berg RL, Glurich IE, Yale SH, Schmelzer JR, Caldwell MD. (2011 November). Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses. Clinical Medicine & Research. 9(3-4):119-24.
    PubMed ID: 21562135
  • Klimant E, Glurich IE, Mukesh BNanjan, Onitilo AA. (2011 November). Blood type, hormone receptor status, her2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort. Clinical Medicine & Research. 9(3-4):111-8.
    PubMed ID: 21263059
  • Caldwell MD, Glurich IE, Pillsbury J, Burmester JK. (2012). Introduction to population diversity and genetic testing. In: Altman RB, Flockhart D, Goldstein DB (Ed.), Principles of Pharmacogenetics and Pharmacogenomics New York, NY:: Cambridge University Press;.
  • Karnik SS, Tan SL, Berg B, Glurich IE, Zhang J, Vidaillet HJ,...Chowdhary R. (2012 April). Predicting Atrial Fibrillation and Flutter using Electronic Health Records. Engineering in Medicine and Biology. 2012 :5562-5.
    PubMed ID: 23367189
  • Myklejord DJ, Yao L, Liang H, Glurich IE. (2012 October). Consensus guideline adoption for managing postoperative nausea and vomiting. WMJ. 111(5):207-13; quiz 214.
    PubMed ID: 23189453
  • Chowdhary R, Tan SL, Pavesi G, Jin J, Dong D, Mathur SK,...Bajic VB [including Glurich IE.] (2012 July). A database of annotated promoters of genes associated with common respiratory and related diseases. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 47(1):112-9.
    PubMed ID: 22383585
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. (2012 July). Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. CANCER CAUSES & CONTROL. 23(7):991-1008.
    PubMed ID: 22527174
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams GH, Doi SA. R.. (2012 June). Diabetes and cancer I: risk, survival, and implications for screening. CANCER CAUSES & CONTROL. 23(6):967-81.
    PubMed ID: 22552844
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Johnson JC, Berg RL. (2012 July). Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience. THROMBOSIS RESEARCH. 130(1):27-31.
    PubMed ID: 22154240
  • Onitilo AA, Kar P, Engel JM, Glurich IE. (2013 April). Long-Term Cardiac and Vascular Disease Outcomes Following Adjuvant Tamoxifen Therapy: Current Understanding of Impact on Physiology and Overall Survival, Minerva Medica. 104(2):141-53.
    PubMed ID: 23514990
  • Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich IE, Williams GA, Doi SA. R.. (2013 December). Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study. Clinical Medicine & Research. 11(4):201-9.
    PubMed ID: 23656798
  • Glurich IE, Chyou P, Engel JM, Cross DS, Onitilo AA. (2013 February). Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association. Clinical Medicine & Research. 11(1):16-25.
    PubMed ID: 23411630
  • Glurich IE, Berg RL, Burmester JK. (2013 June). Does CALU SNP rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Requirements? Clinical Medicine & Research. 11(2):73-9.
    PubMed ID: 23656803
  • Glurich IE, Acharya A, Shukla SK, Nycz G, Brilliant MH. The oral-systemic personalized medicine model at Marshfield Clinic. ORAL DISEASES. 2013 January; 19(1):1-17. doi: 10.1111/j.1601-0825.2012.01921.x. PMCID: PMC3389173.
    PubMed ID: 22458294
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Berg RL. (2013 June). Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. THROMBOSIS RESEARCH. 131(6):567-8.
    PubMed ID: 23497923
  • Onitilo AA, Berg RL, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. (2013 August). Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 8(8):E70426.
    PubMed ID: 23936428
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. (2014 March). Type 2 diabetes mellitus, glycemic control, and cancer risk. EUROPEAN JOURNAL OF CANCER PREVENTION. 23(2):134-40.
    PubMed ID: 23962874
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. (2014 March). Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. EUROPEAN JOURNAL OF CANCER PREVENTION. 23(2):76-83.
    PubMed ID: 23571511
  • Glurich I, Shukla S, Acharya A, Ginsburg GS, Brilliant MH. (2015). The oral microbiome and its relationship to genomics and oral disease. In: Sonis ST (Ed.), Genomics, Personalized Medicine, and Oral Disease. (pp. 35-65). Geneva, Switzerland: Springer International Publishing.
  • Glurich I, Acharya A, Brilliant MH, Shukla SK. (2015 September 4). Progress in oral personalized medicine: contribution of 'omics'. J Oral Microbiol. 7 :28223.
    PubMed ID: 26344171
  • Peissig PL, Nikolai A, Glurich I, Brilliant M. (2015 March 20). Drug Discover and Evaluation: Pharmacological Assays. Personalized Medicine. :1-16.
  • Peissig PL, Nikolai A, Glurich I, Brilliant M. (2016). Personalized Medicine. In: Hock FJ (Ed.), Drug Discovery and Evaluation: Pharmacological Assays. (pp. 4235-4249). Switzerland: Springer International Publishing.
  • Shimpi N, Schroeder D, Kilsdonk J, Chyou PH, Glurich I, Acharya A. (2016 February 8). Assessment of Dental Providers’ Knowledge, Behavior and Attitude towards Incorporating Chairside Screening for Medical Conditions: A Pilot Study. Journal of Dentistry and Oral Care Medicine. 2(1):102.
  • Shimpi N, Schroeder D, Kilsdonk J, Chyou PH, Glurich I, Penniman E, Acharya A. (2016 March). Medical Providers' Oral Health Knowledgeability, Attitudes, and Practice Behaviors: An Opportunity for Interprofessional Collaboration. J Evid Based Dent Pract. 16(1):19-29.
    PubMed ID: 27132552
  • Shimpi N, Bharatkumar A, Jethwani M, Chyou PH, Glurich I, Blamer J, Acharya A. Knowledgeability, Attitude and Behavior of Primary Care Providers Towards Oral Cancer: a Pilot Study. [published online ahead of print 2016 July 23]. J Cancer Educ. 2018 Apr(33(2)):359-364. doi: 10.1007/s13187-016-1084-4.
    PubMed ID: 27448614
  • Panny A, Glurich I, Haws RM, Acharya A. (2017 June 1). Oral and Craniofacial Anomalies of Bardet-Biedl Syndrome: Dental Management in the Context of a Rare Disease. J Dent Res. :22034517716913.
    PubMed ID: 28662344
  • Glurich I, Nycz G, Acharya A. (2017 June). Status Update on Translation of Integrated Primary Dental-Medical Care Delivery for Management of Diabetic Patients. Clin Med Res. 15(1-2):21-32.
    PubMed ID: 28373288
  • Glurich I, Schwei KM, Lindberg S, Shimpi N, Acharya A. (2017 October 1). Integrating Medical-Dental Care for Diabetic Patients: Qualitative Assessment of Provider Perspectives. Health Promot Pract. :1524839917737752.
    PubMed ID: 29073800
  • Shimpi N, Ye Z, Koralkar R, Glurich I, Acharya A. Need for diagnostic-centric care in dentistry: A case study from the Marshfield Clinic Health System. J Am Dent Assoc. 2018 February; 149(2):122-131. doi: 10.1016/j.adaj.2017.09.030. PMCID: PMC5798006.
    PubMed ID: 29389335
  • Shimpi N, Jethwani M, Bharatkumar A, Chyou PH, Glurich I, Acharya A. Patient awareness/knowledge towards oral cancer: a cross-sectional survey. BMC Oral Health. 18(1):86. doi: 10.1186/s12903-018-0539-x. PMCID: PMC5952627.
    PubMed ID: 29764414
  • Hegde H, Shimpi N, Glurich I, Acharya A. Tobacco use status from clinical notes using Natural Language Processing and rule based algorithm. Technol Health Care. 2018 June 29; 26(3):445-456. doi: 10.3233/THC-171127.
    PubMed ID: 29614708
  • Shimpi N, Glurich I, Schroeder D, Katrak C, Chyou PH, Acharya A. Patient Awareness of Association of Diabetes and Periodontal Disease. [published online ahead of print 2018 September 21]. Health Promot Pract. 20201, May(21(3)):464-472. doi: 10.1177/1524839918801909. PMCID: PMC5952627.
    PubMed ID: 30238811
  • Glurich I., Shimpi N., Acharya A.. . Interdisciplinary Care Model: Chronic Kidney Disease and Oral Health. In: Integration of Medical and Dental Care and Patient Data.. 2nd ed.Switzerland: Springer Nature Switzerland AG; 2019: pp. 87-107.
  • Glurich I., Shimpi N., Scannapieco F., Vedre J.. . Interdisciplinary Care Model: Pneumonia and Oral Health. In: Integration of Medical and Dental Care and Patient Data.. 2nd ed.Switzerland: Springer Nature Switzerland AG; 2019: pp. 123-139.
  • Shimpi N., Glurich I., Acharya A.. . Integrated Care Case Study: Marshfield Clinic Health System. In: Integration of Medical and Dental Care and Patient Data.. 2nd ed.Switzerland: Springer Nature Switzerland AG; 2019: pp. 315-326.
  • Delli K, Villa A, Farah CS, Celentano A, Ojeda D, Peterson D,...Vissink A [including Glurich I.] World Workshop on Oral Medicine VII: Biomarkers predicting lymphoma in the salivary glands of patients with Sjögren's syndrome. A systematic review. [published online ahead of print 2019 January 21]. Oral Dis. doi: 10.1111/odi.13041.
    PubMed ID: 30663837
  • Shimpi N, Glurich I, Panny A, Acharya A. Knowledgeability, Attitude and Practice Behaviors of Primary Care Providers Towards Managing Patient's Oral Health in Medical Practice: Wisconsin Statewide Survey. [published online ahead of print 2019 August 22]. J Am Dent Assoc. 2019 Oct(150(10)):863-872. doi: 10.1016/j.adaj.2019.05.020. PMCID: PMC6765414.
    PubMed ID: 31446976
  • Glurich I, Zhang L, Berg R, Acharya A. Periodontitis and CKD: Parallel Examination of Prevalence and Longitudinal Exacerbation. J Dent Res. 2019 June; (98 (Spec Iss A): 3876):iadr.org.
  • Steinmetz A, Glurich I, Panny A, Berg R, Fischer G, Acharya A. HbA1C Screening in the Dental Setting. J Dent Res. 2019 June; (98 (Spec Iss A): 1782):iadr.org.
  • Shimpi N, Zhang L, Jhagroo R, Acharya A, Glurich I. Dental Pulp Stones Prevalence in Patients with Nephrolithiasis and Co-morbidities. J Dent Res. 2019 June; (98 (Spec Iss A): 1796):iadr.org.